EAACI 2011 – a priority for Airsonett
Airsonett is one of EAACI’s Founder Sponsors since 2010, a long-term commitment which, among other things, signify a major investment in the yearly EAACI congress in Istanbul 11 – 15…
Follow the latest news from Airsonett and insights in allergic diseases such as asthma and atopic dermatitis here. Please contact us here if you would like more information or press materials.
Airsonett is one of EAACI’s Founder Sponsors since 2010, a long-term commitment which, among other things, signify a major investment in the yearly EAACI congress in Istanbul 11 – 15…
Thomas Axelsson has been elected new Chairman of the Airsonett board starting on December 15, 2010. Thomas Axelsson is currently an active chairman in various companies and runs his own…
Preparation Rooms at the hospital operating wards are becoming more and more common as a way to increase productivity and to prepare sterile instruments and other surgical equipment in a…
After an exceptional response after the EAACI (European Academy of Allergy and Clinicial Immunology) congress in London earlier this summer, where the first results from the 4A-study were made public,…
The private hospital Hjerte Center in Varde, founded in 1998, built a brand new hospital in southern Denmark in 2010. The new building, which includes three buildings of approx. 5000…
Art Clinic has decided to build a brand new hospital with three state of the art operating theaters and 18 ward and examination rooms, in Jönköping, Sweden. The construction of…
Art Clinic AB har beslutat sig för att uppföra ett helt nytt sjukhus med tre toppmoderna operationsrum, 18 vårdplatser och undersökningsrum i Jönköping. Uppförandet av sjukhuset kommer att ske under 2011…
Airsonett har anställt ytterligare en medarbetare, Linda Berndtsson som är företagets nya Director of Quality Assurance (QA) & Regulatory Affairs (RA). Linda kommer att bygga upp kvalitetssystem i samband med…
The information on this website is intended for residents of the United States only. The product described here is FDA 510(k) cleared for use in the United States. Product indications and availability may differ in other regions.